Anavex Life Sciences Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0HFR.L | AMLX | NBIX | AXSM | ACAD | TNXP | |
|---|---|---|---|---|---|---|
| Market cap | — | 3.59B | 14.57B | 8.18B | 3.50B | 87.98M |
| P/E (TTM) | — | — | 21.0 | — | 9.1 | — |
| Forward P/E | — | -26.2 | 12.0 | 42.3 | 22.1 | -0.7 |
| Price/book | 1.1 | 13.3 | 3.9 | 98.0 | 2.7 | 0.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −43.99% | +99.65% | −0.26% | +22.83% | −6.53% | −72.39% |
| Today | −2.13% | −1.58% | +1.40% | −0.15% | +0.59% | −5.52% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All 0HFR.L news ›Deadline Alert: Anavex Life Sciences Corp. Investors Have Until November 30, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds
October 19, 2026 18:10 ET | Source: Glancy Prongay Wolke & Rotter LLP Glancy Prongay Wolke & Rotter LLP Investors who suffered losses on Anavex Life Sciences Corp. investments can contact Glancy about the Anavex Life Sciences Corp. class…
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AVXL
October 19, 2026 4:08 PM EDT | Source: The Rosen Law Firm PA New York, New York--(Newsfile Corp. - October 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp.…
Kaplan Fox Reminds Anavex Life Sciences Corp. (AVXL) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 30, 2026
October 19, 2026 5:30 AM EDT | Source: Kaplan Fox & Kilsheimer LLP New York, New York--(Newsfile Corp. - October 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Anavex Life Sciences…
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Anavex Life Sciences Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno The National Law Review AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Anavex Life Sciences Corp. Investors with Substantial Losses Have…
Anavex Life Sciences (AVXL) Gains FDA IND Approval for Fragile X Syndrome Trial
While the company’s stock price has declined sharply over the past year—down over 58% year-to-date and 83.6% over 52 weeks—this reflects the high-risk nature of early-stage biotech investing. The GF Value™ metric is not reliable for AVXL…
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between... NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor…
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines - AVXL
PR Newswire NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL). Such investors are advised to contact…
AVXL Investors: Anavex Life Sciences Corp. Shares Declined By $0.19 On August 31, 2026 – Contact Kirby McInerney LLP to Discuss Your Rights
FinancialContent AVXL Investors: Anavex Life Sciences Corp. Shares Declined By $0.19 On August 31, 2026 – Contact Kirby McInerney LLP to Discuss Your Rights If you have suffered a loss on your Anavex Life Sciences Corp. (“Anavex” or the…
NOTICE: Lawsuit filed in effort to recover losses for Investors in Anavex Life Sciences Corp. (NASDAQ: AVXL)
An investor who purchased shares of Anavex Life Sciences Corp NASDAQ AVXL filed a lawsuit over alleged violations of Federal Securities Laws by Anavex Life Sciences Corp in connection with certain allegedly false and misleading statements…
Class action lawsuit filed against Anavex Life Sciences over CEO firing and financial control issues.
Pomerantz LLP has filed a class action lawsuit against Anavex Life Sciences Corp. following the abrupt firing of its CEO for cause and the company's disclosure of a material weakness in financial controls. The CEO's termination…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
newsfilecorp.com13
-
prnewswire.com12
-
globenewswire.com9
-
accessnewswire.com7
-
natlawreview.com6
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 63 articles, not a forecast.